| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |